Commure raises $70M at $7B valuation for healthcare AI
What's the deal? Commure, a California-based AI platform for healthcare, has raised $70 million in a funding round that values the company at $7 billion. General Catalyst led the round, with participation from Sequoia Capital, Morgan StanleyDealroom has a profile for this one. Try Dealroom →, and Kirkland & EllisDealroom has a profile for this one. Try Dealroom →.
The company builds AI agents and automation tools that embed directly into healthcare workflows, targeting the administrative burden that it says costs roughly $1 trillion annually across the US. Commure plans to use the funds to scale its revenue cycle and practice management platform and expand into international markets.
Why now? Agentic AI — systems that can plan, decide, and act autonomously rather than just respond to prompts — has become one of venture capital's hottest categories. Investors are pouring money into companies that use the technology to streamline operations, and healthcare's massive administrative overhead makes it a prime target.
Commure's tools are already deployed across more than 500 healthcare organisations and 3,000 sites of care, including major systems like HCA HealthcareDealroom has a profile for this one. Try Dealroom → and Tenet HealthcareDealroom has a profile for this one. Try Dealroom →. Its revenue cycle management platform completes more than 85% of work without human intervention, and its Ambient AI suite supports tens of millions of appointments annually.
"For thirty years, healthcare was told software would fix administrative work. It didn't, because software could not actually do the work," said Tanay TandonDealroom has a profile for this one. Try Dealroom →, chief executive officer of Commure. "AI can."
What could go wrong? Healthcare is among the most heavily regulated industries, and deploying autonomous AI agents in clinical and billing workflows carries significant compliance and accuracy risks. Errors in coding, claims, or documentation could expose health systems to legal and financial liability.
The company also integrates with more than 60 electronic health record systems — a breadth that introduces complexity as it scales internationally, where regulatory frameworks and data privacy rules vary widely.
The signal: Commure's round reflects a broader shift in healthcare AI from copilot-style assistants to fully autonomous agents that execute tasks end to end. As Hemant TanejaDealroom has a profile for this one. Try Dealroom →, chief executive officer of General Catalyst, put it: "Commure is doing it not as a feature or co-pilot, but as a system of agents completing administrative and clinical work in fundamentally modern ways."
With $70 million at a $7 billion valuation, the round is relatively modest in size — suggesting either strong capital efficiency or a company choosing to raise strategically rather than dilute heavily. Either way, it signals growing investor conviction that agentic AI in healthcare is moving from pilot to production.
Read more: Commure · FierceHealthcare · FinSMEs
Image credit: Commure
J.V.
